Understanding Lyme disease treatment cost in London means understanding what the assessment is designed to uncover.
For a recent infection, standard acute care focuses on timely diagnosis and antibiotic treatment.
For people with persistent, fluctuating, or multisystem symptoms, the clinical question is often broader: what factors may be affecting immune regulation, recovery, and the overall symptom picture?
Many people exploring private Lyme disease support have already had tests, completed treatment, or seen several specialists, yet still do not have an explanation that connects their symptoms.
A systemic functional assessment looks beyond a single result to map the full timeline, including possible tick exposure, previous investigations, treatment response, co-infections, gut and immune health, nutrition, sleep, hormonal balance, and stress.
This article explains the likely costs of that more comprehensive approach, what may be included at each stage, and how to judge whether the depth of assessment matches the complexity of your case.
| This article is for informational purposes only and does not constitute medical advice. If you are experiencing symptoms of Lyme disease, please consult a qualified healthcare professional. |
Standard Acute Care and Systemic Assessment
For acute, early-stage Lyme disease, NHS care remains vital. NICE guidance recommends antibiotic treatment according to the clinical presentation, with common adult regimens lasting 21 to 28 days.
This acute pathway is designed to diagnose and treat infection promptly. In longer-standing or complex cases, however, patients may be dealing with what feels like “smoldering systemic damage” – persistent inflammatory, neurological, immune, or multisystem effects that are not captured by a single acute-care episode.
These symptoms do not prove that active infection is continuing, and alternative diagnoses must still be investigated, but they can justify a wider systemic assessment of the factors affecting recovery.
In the UK, Lyme disease is spread by the bite of Ixodes ricinus ticks (commonly known as sheep or deer ticks), and is most often caused by Borrelia afzelii and Borrelia garinii, the strains most associated with Lyme disease in the UK and Europe.
Lyme disease testing is most useful when it is interpreted in context. NICE advises clinicians to use a combination of clinical presentation and laboratory testing in people without an erythema migrans rash, and not to rule out Lyme disease solely because a test is negative when clinical suspicion remains high. Antibody levels may not yet be detectable early in infection, so repeat testing may be recommended.
The timing of the test, the symptom pattern, previous treatment, and possible exposure all matter.
For people who complete a course of antibiotics and still experience fatigue, brain fog, and joint pain, this is sometimes described clinically as Post-Treatment Lyme Disease Syndrome (PTLDS) — a recognised, though still actively researched, clinical picture (Rebman & Aucott, 2020).
You may also see the term “chronic Lyme disease” used informally online. It isn’t a diagnosis used in UK clinical guidelines; PTLDS is the term you’re more likely to hear from a UK clinician.
For patients with persistent or multisystem symptoms, the question is therefore not simply NHS care or private care. It is whether the assessment is broad enough to understand the full pattern, consider alternative diagnoses, and identify what further support may be appropriate.
Private Consultation Costs
At London Clinic of Nutrition, Lyme disease support is built around understanding the full pattern rather than relying on a tick bite or single result.
The assessment may cover symptom chronology, previous investigations and treatment response, possible co-infections, immune and gut function, nutritional status, sleep, hormonal balance, and wider stress-related factors that may be contributing to ongoing symptoms.
A typical Lyme disease support package may cost around £995. Testing is charged separately and usually ranges between £350 and £700, depending on what is clinically appropriate for your case.
Individual consultation fees may be priced separately depending on the practitioner and the level of support required. You can see the current consultation fees on our services page.
Any testing, further appointments, or additional treatment costs are always discussed with you directly before anything is booked, so you know what to expect and why.
Testing Costs and Broader Clinical Assessment
Lyme disease testing is often misunderstood. A negative ELISA result does not always close the question, particularly when testing was carried out before antibodies had time to develop.
False negatives in standard protocols can become a significant barrier to recovery when they delay further clinical review, specialist referral, or appropriate next steps.
NICE recognises that false-positive and false-negative results can occur and recommends reviewing the clinical history, repeating or extending testing in defined circumstances, and considering alternative diagnoses. This is why a result should never be interpreted in isolation.
At London Clinic of Nutrition, the clinical assessment uses broader diagnostic criteria beyond standard ELISA testing. This does not mean dismissing validated laboratory methods.
It means interpreting appropriate accredited testing alongside the timing and migratory pattern of symptoms, possible tick exposure, previous treatment, neurological or sensory features, immune patterns, co-infection risk, and the wider health picture.
Your practitioner will explain what is being suggested, why it may be useful, and how it fits into the wider care plan before anything is ordered.
No Surprise Costs
Because Lyme disease cases can vary so much, your practitioner will always talk you through the recommended plan before anything is booked or ordered.
This includes consultation structure, testing, follow-up appointments, and any additional support that may be appropriate for your case. The aim is to make sure you understand what is being recommended, why it matters, and what it will cost before you commit.
What Influences Overall Treatment Costs
There isn’t a single fixed cost for treating Lyme disease, because no two cases look the same. A few things tend to make the biggest difference:
Stage of illness.
Someone with a recent tick bite and early symptoms usually needs fewer appointments and less testing than someone who has been unwell for a long time without a clear diagnosis.
Co-infections.
When Babesia or Anaplasma exposure is suspected alongside Lyme disease, your clinician may recommend additional testing and a longer treatment plan, which adds to the overall cost.
Type of treatment.
Oral antibiotic courses are generally the least expensive option. In more complex or neurological presentations, intravenous antibiotics may be considered under close medical supervision. This decision is made by the treating clinician on a case-by-case basis and would typically sit within a hospital or specialist infectious disease setting, rather than a standard private consultation.
Depth of systemic assessment.
A complex case may require a longer health history, review of multiple previous results, consideration of co-infections and alternative diagnoses, and assessment of gut, immune, nutritional, hormonal, sleep, and stress-related factors. The additional clinical time and coordination are reflected in the cost.
Every treatment decision, including whether further testing or additional support is appropriate, is made by your clinician based on your individual case. We can’t promise a particular outcome or timeline — everyone’s situation is different.
Why Functional Medicine Costs More
It’s a fair question: why can functional medicine Lyme disease support cost more than a standard acute-care appointment? The answer is not simply that the consultation is longer.
The scope is different: the aim is to build a connected picture of a complex illness rather than assess one symptom, one organ system, or one test result at a time.
Standard acute care is essential for identifying and treating infection. A systemic functional assessment adds another layer for people whose symptoms persist, fluctuate, or involve several body systems.
It may include detailed symptom mapping, review of previous investigations and treatment response, consideration of co-infections and alternative diagnoses, and assessment of gut health, immune regulation, nutritional status, sleep, hormones, and lifestyle factors. This depth helps explain why the cost is higher.
One concept that may form part of this wider assessment is allostatic load: the cumulative physiological strain associated with repeated or chronic stress.
Long-term stress, including the lasting effects of adverse childhood experiences, can influence neuroendocrine, inflammatory, sleep, and immune processes.
This does not mean that stress causes Lyme disease or proves that an infection is persisting. It means that recovery and symptom burden may be shaped by the body’s wider regulatory environment, which is why a whole-person history can be clinically relevant (Juster et al., 2010; Chen et al., 2021).
This is not about claiming that functional medicine cures Lyme disease. It is about providing a more personalised investigative process for complex cases, while using conventional medical evaluation and treatment where appropriate.
The value lies in the time taken to connect the patient’s history, identify clinically relevant patterns, decide which tests are justified, and build an individualised plan rather than applying a single standard protocol.
Why Lyme is Often Misdiagnosed as an Autoimmune Condition
Lyme disease is sometimes described as a ‘great imitator’ because its symptoms can overlap with many other conditions. NICE includes migratory joint or muscle pain, cognitive changes, and paraesthesia among the features that may prompt consideration of
Lyme disease, while also stressing that it is an uncommon cause of these symptoms and that alternative diagnoses must be assessed.
Dr Richard Horowitz’s Multiple Systemic Infectious Disease Syndrome (MSIDS) framework is one clinician-developed model used to organise complex symptom patterns.
It gives particular weight to symptoms that wax and wane or move between areas of the body, alongside fatigue, cognitive problems, and neuropathic symptoms such as numbness, tingling, or burning.
Neurological and sensory features may also include tinnitus, floaters, and visual snow – persistent static-like dots across the field of vision.
These features may form part of a broader clinical history, but none is diagnostic of Lyme disease on its own and each can have other causes that require appropriate assessment (Horowitz et al., 2017; Horowitz and Freeman, 2018; Horowitz and Freeman, 2022).
Because these symptoms can also occur in multiple sclerosis, rheumatoid arthritis, lupus, fibromyalgia, and other neurological, rheumatological, or pain conditions, a comprehensive assessment should not assume that Lyme disease is the hidden cause.
Its purpose is to examine exposure, timing, migratory patterns, validated test results, and treatment history, while identifying when infectious disease, rheumatology, neurology, or other specialist input is needed.
How Our Approach Differs
At London Clinic of Nutrition, our practitioners regularly see patients who have spent years trying to make sense of symptoms that cross several body systems.
The assessment is designed to connect information that may otherwise sit in separate appointments: the sequence and movement of symptoms, previous testing and treatment response, possible co-infections, gut and immune health, hormonal balance, nutrition, sleep, and stress.
The aim is not to label every complex presentation as Lyme disease or to replace appropriate NHS and specialist care.
It is to provide a more complete investigative framework, recognise patterns that may justify further assessment, and build a personalised plan around the factors that are clinically relevant to the individual.
Frequently Asked Questions
For acute, early-stage Lyme disease, yes. A positive test result or a clear clinical diagnosis from your GP leads to NHS antibiotic treatment at no cost. Gaps tend to appear for patients with ongoing symptoms after treatment, or where NHS testing hasn’t given a clear result.
At London Clinic of Nutrition, Lyme disease testing usually ranges between £350 and £700, depending on what is clinically justified for your case. The assessment uses broader diagnostic criteria beyond standard ELISA testing by considering the timing of previous tests, exposure history, migratory symptom patterns, treatment response, neurological or sensory features, and whether co-infections or wider immune factors require consideration. Testing should be carried out through appropriately accredited laboratories using validated methods, and the purpose and cost will be explained before anything is ordered.
For early-stage Lyme disease, a short course of antibiotics is often enough. For people with PTLDS or longer-standing symptoms, support may continue for several months. This depends on the stage of infection, whether co-infections are present, and how each person responds it’s something your clinician will talk through with you directly rather than promise upfront.
Post-Treatment Lyme Disease Syndrome (PTLDS) describes symptoms including fatigue, brain fog, and joint pain that persist after a completed course of antibiotics. It’s a recognised clinical picture, though the underlying causes are still being researched, and management approaches can vary between clinicians.
You’ll often see this term used informally, but it isn’t a diagnosis recognised in UK clinical guidelines. PTLDS is the term you’re more likely to come across in a UK clinical setting, and it describes persistent symptoms after treatment rather than an ongoing active infection.
Standard acute care focuses on diagnosing and treating infection and is essential when Lyme disease is suspected. A functional medicine assessment is broader and is most relevant when symptoms are persistent, fluctuating, or multisystem. It brings together exposure history, symptom chronology, previous results, and treatment response with assessment of gut, immune, nutritional, hormonal, sleep, and stress-related factors. It should complement, not replace, appropriate medical investigation.
Functional medicine costs reflect the scope of the assessment, not simply the length of the appointment. Clinical time is spent mapping a detailed history, reviewing previous results, deciding whether further validated testing or specialist input is justified, and building a personalised plan around the factors most relevant to the patient. That additional investigation and coordination are reflected in the cost.
If you have a recent tick bite, an erythema migrans rash, or new symptoms, contact your GP promptly so acute Lyme disease can be assessed and treated. If you have already completed testing or treatment but persistent symptoms remain unexplained, a more comprehensive consultation may help organise the history, review whether further validated testing or specialist referral is appropriate, and clarify a personalised plan.
| Still searching for answers? Many of our patients come to us after years of feeling unwell, with test results that came back normal and symptoms that were never fully explained. A complimentary discovery call is the starting point. It’s an opportunity to discuss your symptoms, ask questions, and understand whether a personalised functional medicine assessment may be appropriate for your situation.Book a complimentary discovery call with the London Clinic of Nutrition. |
References
National Institute for Health and Care Excellence (NICE). Lyme disease. NICE guideline NG95, 2018.
UK Health Security Agency (UKHSA). Lyme disease guidance, data and analysis. gov.uk.
Rebman AW, Aucott JN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Frontiers in Medicine, 2020. DOI: 10.3389/fmed.2020.00057.
Citera M, Freeman PR, Horowitz RI. Empirical validation of the Horowitz Multiple Systemic Infectious Disease Syndrome Questionnaire for suspected Lyme disease. International Journal of General Medicine. 2017;10:249-273. DOI: 10.2147/IJGM.S140224.
Horowitz RI, Freeman PR. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2. Healthcare. 2018;6(4):129. DOI: 10.3390/healthcare6040129.
Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neuroscience & Biobehavioral Reviews. 2010;35(1):2-16. DOI: 10.1016/j.neubiorev.2009.10.002.
Chen MA, LeRoy AS, Majd M, Chen JY, Brown RL, Christian LM, Fagundes CP. Immune and Epigenetic Pathways Linking Childhood Adversity and Health Across the Lifespan. Frontiers in Psychology. 2021;12:788351. DOI: 10.3389/fpsyg.2021.788351.
Horowitz RI, Freeman PR. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review. Antibiotics. 2022;11(7):912. DOI: 10.3390/antibiotics11070912.
The London Clinic of Nutrition
A multi-disciplined functional medicine practice helping thousands of people with complex chronic conditions for over 10 years. Winner of the IHCAN ‘Outstanding Contribution to the Community’ award. More 5-star Google reviews than any other clinic of its nature in Europe.